Alzheimer, Rivastigmine
Showing 1 - 25 of 482
Alzheimer, CVA (Cerebrovascular Accident) Trial in Singapore (Rivastigmine)
Completed
- Alzheimer Disease
- CVA (Cerebrovascular Accident)
-
Singapore, SingaporeNational Neuroscience Institute
Mar 3, 2021
Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)
Recruiting
- Depressive Disorder
- Rivastigmine Transdermal Product
- Sham
-
Utrecht, NetherlandsUMC Utrecht
Mar 2, 2023
Mild to Moderate Alzheimer's Disease Trial in Japan (Rivastigmine Patch)
Completed
- Mild to Moderate Alzheimer's Disease
- Rivastigmine Patch
-
Fukuoka city, Fukuoka, Japan
- +18 more
Aug 5, 2019
Alzheimer's Disease Trial (Thymatron IV device (Somatics))
Not yet recruiting
- Alzheimer's Disease
- Thymatron IV device (Somatics)
- (no location specified)
Apr 21, 2021
Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)
Not yet recruiting
- Alzheimer Disease
- Placebo
- +2 more
-
Paris, FranceInstitut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022
Nutraceuticals and Drug Treatment in Frail Older Adults
Recruiting
- Frailty
- Nutraceuticals
-
Naples, It, ItalyPasquale Mone
May 4, 2022
Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)
Recruiting
- Hallucinations, Auditory
- Psychosis
- Rivastigmine Transdermal Product
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Mar 2, 2022
Alzheimer Trial in Canada (Montelukast buccal film, Placebo buccal film)
Recruiting
- Alzheimer Disease
- Montelukast buccal film
- Placebo buccal film
-
Victoria, British Columbia, Canada
- +12 more
Jul 21, 2022
Parkinson Disease, Memory Disorders Trial in Toronto (NBM stimulation using the Vercise device (Boston Scientific, Marlborough,
Completed
- Parkinson Disease
- Memory Disorders
- NBM stimulation using the Vercise device (Boston Scientific, Marlborough, Massachusetts, US)
-
Toronto, Ontario, CanadaToronto Western Hospital
Nov 1, 2022
Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)
Active, not recruiting
- Bioequivalence
- Rivastigmine twice-weekly 9,5 mg/24 h
- Exelon® 9.5 mg/24 h
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023
Alzheimer Trial in Istanbul (device, other, drug)
Completed
- Alzheimer Disease
- Repetitive Transcranial Magnetic Stimulation
- +3 more
-
İstanbul, Beykoz, TurkeyIstanbul Medipol University
Oct 21, 2021
Diabetes in Elderly People With Dementia in France
Completed
- Alzheimer Disease
- Incidence analysis
-
Toulouse, FranceUniversity Hospital
Aug 31, 2021
Transcranial Random Noise, Electroencephalography, Alzheimer Trial in Hefei (High frequency transcranial random noise, Sham high
Recruiting
- Transcranial Random Noise
- +2 more
- High frequency transcranial random noise
- Sham high frequency transcranial random noise
-
Hefei, Anhui, ChinaAnhui Medical University
Jun 3, 2023
Alzheimer's Disease, Dementia, Brain Diseases Trial in Daejeon, Busan, Seoul (ATNC MDD-V1 (Real TMS + Real Cog), ATNC MDD-V1
Recruiting
- Alzheimer's Disease
- +7 more
- ATNC MDD-V1 (Real TMS + Real Cog)
- ATNC MDD-V1 (Sham TMS + Real Cog)
-
Daejeon, Jung-gu, Korea, Republic of
- +2 more
Oct 11, 2023
Dementia, Dementia, Vascular, Dementia With Lewy Bodies Trial in United States (Care Ecosystem)
Not yet recruiting
- Dementia
- +4 more
- Care Ecosystem
-
San Francisco, California
- +5 more
Dec 20, 2022
Alzheimer, Early Onset, Parkinson Disease Trial in Rennes (fMRI, CONFMEM)
Not yet recruiting
- Alzheimer Disease, Early Onset
- Parkinson Disease
- fMRI
- CONFMEM
-
Rennes, FranceCHU Rennes
Oct 5, 2023
Patients With Cognitive and Behavioral Disorders
Not yet recruiting
- Behavioral Variant of Frontotemporal Disorder (bvFTD)
- +3 more
- Submission of the NEO-PI-3 questionnaire
- Submission of the Interpersonal Reactivity Index questionnaire (IRI)
- (no location specified)
Sep 29, 2023
Alzheimer Trial in Besiktas (Semantic Recognition Procedure)
Recruiting
- Alzheimer Disease
- Semantic Recognition Procedure
-
Beşiktaş, İstanbul, TurkeyJbid Dursun Uncu
Feb 2, 2023
To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Trial in Kaohsiung (Astaxanthin, Placebo)
Active, not recruiting
- To Evaluate the Possible Benefit of Astaxanthin on Alzheimer Disease
- Astaxanthin
- Placebo
-
Kaohsiung, TaiwanKaohsiung Medical University Chung-Ho Memorial Hospital
Aug 15, 2022
Alzheimer Trial in Izmir (Dual-Task Training, Control Group)
Not yet recruiting
- Alzheimer Disease
- Dual-Task Training
- Control Group
-
İzmir, Karsıyaka, TurkeyKarsiyaka Municipality Day Living Center
Mar 1, 2023
Alzheimer Trial (RB-ADSC)
Not yet recruiting
- Alzheimer Disease
- RB-ADSC
- (no location specified)
Dec 19, 2022
Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects
Recruiting
- Motoric Cognitive Risk Syndrome
- +3 more
- MRI evaluation
- +3 more
-
Caen, FranceCHU de Caen Normandie
Nov 28, 2022